Jeffrey C. Goh - Researcher Profile | RDL Research Database

Publications

2 shown

Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma

Robert J. Motzer , B. Yа. Alekseev , Sun Young Rha +35 more

Lenvatinib plus pembrolizumab was associated with significantly longer progression-free survival and overall survival than sunitinib. (Funded by Eisai and Merck Sharp and Dohme;...

2021 New England Journal of Medicine 1597 citations

Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma

Toni K. Choueiri , Thomas Powles , Mauricio Burotto +28 more

Nivolumab plus cabozantinib had significant benefits over sunitinib with respect to progression-free survival, overall survival, and likelihood of response in patients with prev...

2021 New England Journal of Medicine 1584 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 3,181
Institution: The University of Queensland

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0003-3103-146X

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.